Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Post-Stroke Pain clinical trials

3 of 5 indexed Post-Stroke Pain trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Post-Stroke Pain: 5 US clinical trials tracked, 3 recruiting.

Post-Stroke Pain is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of California, San Francisco, running 2 of these trials.

Enrollment posture brief

Registry condition post-stroke-pain

OPEN 3 | RECR 60% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Post-Stroke Pain (this)60%
Open-enrollment share among volume-matched conditions near Post-Stroke Pain

Post-Stroke Pain lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Post-Stroke Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Post-Stroke Pain is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Post-Stroke Pain research.

    University of California, San Francisco accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Post-Stroke Pain trials plan to enrol fewer than 100 people.

    Median target enrolment is 24 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Post-Stroke Pain research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Post-Stroke Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Low Frequency rTMS Device
1 trials
High Frequency rTMS Device
1 trials
Closed-Loop DBS Device
1 trials
Open-Loop DBS Device
1 trials
Transcutaneous Auricular Neurostimulation Device
1 trials
Scrambler Therapy for Post Stroke Pain Device
1 trials
Sham Stimulation Device
1 trials
Medtronic Summit RC+S or Percept RC Device
1 trials

US sites by state

Facility locations filed on Post-Stroke Pain trials. A trial with sites in several states counts in each.

California 3 trials
South Carolina 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Post-Stroke Pain page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post-Stroke Pain condition card totals 5 registered trials; most-linked intervention Low Frequency rTMS; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.